Barclays analyst Andrew Mok CFA maintained a Hold rating on DaVita (DVA – Research Report) today and set a price target of $169.00. The company’s shares closed yesterday at $152.86.

The current dialysis market is highly concentrated, with two large corporations, DaVita and Fresenius, owning 75 percent of the dialysis market, and more than 25 percent of patients with ESRD ...

The author shares meals inspired by her years as a mom and grandmother. Drawing from decades of experience feeding her family, Babs Costello shares delicious, family-approved recipes in her new ...

DENVER — New details have emerged about the workforce housing project being developed in downtown for one of Denver's highest-profile employers. In June, Denver-based DaVita Inc. (Nasdaq: DAV ...

Meatloaf? Yes, meatloaf. Hear us out. This hearty recipe is not only easy to make for the host but it's a great dish for serving along with creamy mashed potatoes and crispy beans. The ultimate ...